Immunohistochemical Study of Metalloproteinases and Their Tissue Inhibitors in the Lungs of Patients with Diffuse Alveolar Damage and Idiopathic Pulmonary Fibrosis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1996 Oct 1

PMID 8863673

Citations 59

Authors

T Hayashi

W G Stetler-Stevenson

M V Fleming

N Fishback

M N Koss

L A Liotta

V J Ferrans

W D Travis

Affiliations

Soon will be listed here.

Abstract

Immunohistochemical and confocal microscopic studies of the localization of matrix metalloproteinases (MMPs), their tissue inhibitors (TIMPs), and type IV collagen were made in lung tissues from patients with normal pulmonary histology (n = 3), diffuse alveolar damage (n = 14), and idiopathic pulmonary fibrosis (n = 12). Pretreatment with pepsin revealed otherwise undetectable MMP- and TIMP-immunoreactive sites. In normal lung, MMP-2, MMP-9, TIMP-1, and TIMP-2 were localized in ciliated cells, endothelial cells, pneumocytes, macrophages, and smooth muscle cells; fibroblasts showed a strong reaction only for MMP-2. Only TIMP-2 showed co-localization with type IV collagen. Myofibroblasts and epithelial cells expressed increased reactivity for MMPs and TIMPs in both disorders. The reactivities for MMPs and TIMPs were stronger in diffuse alveolar damage. MMP-2 showed focal co-localization in capillary endothelial and disrupted epithelial basement membranes, suggesting activation of collagenolysis. A protective effect against this lysis was suggested by the extensive co-localization of TIMP-2 with type IV collagen and fibrillar collagens. Alveolar buds showed increased reactivity for MMPs and TIMPs in their lining epithelial cells, myofibroblasts, and their basement membranes; however, their matrices were mostly unreactive. These findings emphasize the complexity of the roles of MMPs and TIMPs in collagen turnover in diffuse alvcolar damage and idiopathic pulmonary fibrosis.

Citing Articles

Allium sativum nanovesicles exhibit anti-inflammatory and antifibrotic activity in a bleomycin-induced lung fibrosis model.

Santos-Alvarez J, Velazquez-Enriquez J, Reyes-Jimenez E, Ramirez-Hernandez A, Iniguez-Palomares R, Rodriguez-Beas C Mol Biol Rep. 2024; 51(1):1166.

PMID: 39560703 DOI: 10.1007/s11033-024-10104-8.

Emerging delivery approaches for targeted pulmonary fibrosis treatment.

Diwan R, Bhatt H, Beaven E, Nurunnabi M Adv Drug Deliv Rev. 2023; 204:115147.

PMID: 38065244 PMC: 10787600. DOI: 10.1016/j.addr.2023.115147.

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease.

Otoshi R, Sekine A, Muraoka T, Iwasawa T, Takemura T, Matsushita S Adv Respir Med. 2023; 91(2):164-173.

PMID: 37102781 PMC: 10135672. DOI: 10.3390/arm91020014.

Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression.

Inoue R, Yasuma T, DAlessandro V, Toda M, Ito T, Tomaru A Int J Mol Sci. 2023; 24(7).

PMID: 37047672 PMC: 10095307. DOI: 10.3390/ijms24076695.

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.

Ishida Y, Kuninaka Y, Mukaida N, Kondo T Int J Mol Sci. 2023; 24(4).

PMID: 36834561 PMC: 9958859. DOI: 10.3390/ijms24043149.

References

Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P, Salo T . Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol. 1993; 101(2):205-10. DOI: 10.1111/1523-1747.ep12363823. View

Hurewitz A, Zucker S, Mancuso P, Wu C, DiMassimo B, Lysik R . Human pleural effusions are rich in matrix metalloproteinases. Chest. 1992; 102(6):1808-14. DOI: 10.1378/chest.102.6.1808. View

Murphy A, Unsworth E, Stetler-Stevenson W . Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 1993; 157(2):351-8. DOI: 10.1002/jcp.1041570219. View

Stricklin G, Li L, Jancic V, Wenczak B, Nanney L . Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol. 1993; 143(6):1657-66. PMC: 1887264. View

Denholm E, Rollins S . Alveolar macrophage secretion of a 92-kDa gelatinase in response to bleomycin. Am J Physiol. 1993; 265(6 Pt 1):L581-5. DOI: 10.1152/ajplung.1993.265.6.L581. View

Stetler-Stevenson W, Aznavoorian S, Liotta L . Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993; 9:541-73. DOI: 10.1146/annurev.cb.09.110193.002545. View

Minoo P, Penn R, deLemos D, Coalson J, deLemos R . Tissue inhibitor of metalloproteinase-1 mRNA is specifically induced in lung tissue after birth. Pediatr Res. 1993; 34(6):729-34. DOI: 10.1203/00006450-199312000-00007. View

Piedboeuf B, Johnston C, Watkins R, Hudak B, Lazo J, Cherian M . Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionein in murine lungs after hyperoxic exposure. Am J Respir Cell Mol Biol. 1994; 10(2):123-32. DOI: 10.1165/ajrcmb.10.2.8110467. View

Litzky L, Lubensky I, Muschel R . Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol. 1994; 144(3):518-27. PMC: 1887096. View

10.

Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H . Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest. 1994; 70(2):176-82. View

11.

Stricklin G, Li L, Nanney L . Localization of mRNAs representing interstitial collagenase, 72-kda gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol. 1994; 103(3):352-8. DOI: 10.1111/1523-1747.ep12394926. View

12.

Sepper R, Konttinen Y, Sorsa T, Koski H . Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest. 1994; 106(4):1129-33. DOI: 10.1378/chest.106.4.1129. View

13.

Stricklin G, Nanney L . Immunolocalization of collagenase and TIMP in healing human burn wounds. J Invest Dermatol. 1994; 103(4):488-92. DOI: 10.1111/1523-1747.ep12395601. View

14.

Cawston T, Galloway W, Mercer E, Murphy G, Reynolds J . Purification of rabbit bone inhibitor of collagenase. Biochem J. 1981; 195(1):159-65. PMC: 1162866. DOI: 10.1042/bj1950159. View

15.

Welgus H, Stricklin G . Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem. 1983; 258(20):12259-64. View

16.

Hembry R, Murphy G, Reynolds J . Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci. 1985; 73:105-19. DOI: 10.1242/jcs.73.1.105. View

17.

Basset F, Ferrans V, Soler P, Takemura T, Fukuda Y, Crystal R . Intraluminal fibrosis in interstitial lung disorders. Am J Pathol. 1986; 122(3):443-61. PMC: 1888228. View

18.

Carmichael D, Sommer A, Thompson R, Anderson D, Smith C, Welgus H . Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A. 1986; 83(8):2407-11. PMC: 323306. DOI: 10.1073/pnas.83.8.2407. View

19.

Weiland J, Garcia J, DAVIS W, Gadek J . Neutrophil collagenase in rheumatoid interstitial lung disease. J Appl Physiol (1985). 1987; 62(2):628-33. DOI: 10.1152/jappl.1987.62.2.628. View

20.

Swanson P, Hagen K, Wick M . Avidin-biotin-peroxidase-antiperoxidase (ABPAP) complex. An immunocytochemical method with enhanced sensitivity. Am J Clin Pathol. 1987; 88(2):162-76. DOI: 10.1093/ajcp/88.2.162. View